The ratio of the yields of antiprotons to protons in pp collisions has been measured by the ALICE experiment at sqrt[s]=0.9 and 7 TeV during the initial running periods of the Large Hadron Collider. The measurement covers the transverse momentum interval 0.45
Charged-particle production was studied in proton-proton collisions collected at the LHC with the ALICE detector at centre-of-mass energies 0.9 TeV and 2.36 TeV in the pseudorapidity range |η| < 1.4. In the central region (|η| < 0.5), at 0.9 TeV, we measure charged-particle pseudo- for non-single-diffractive collisions. The relative increase in charged-particle multiplicity from the lower to higher energy is 24.7% ± 0.5%(stat.) +5.7 −2.8 %(syst.) for inelastic and 23.7% ± 0.5%(stat.) +4.6 −1.1 %(syst.) for non-single-diffractive interactions. This increase is consistent with that reported by the CMS collaboration for non-single-diffractive events and larger than that found by a number of commonly used models. The multiplicity distribution was measured in different pseudorapidity intervals and studied in terms of KNO variables at both energies. The results are compared to protonantiproton data and to model predictions.
Central collisions of gold nuclei are simulated by several existing models
and the central net baryon density rho and the energy density eps are extracted
at successive times, for beam kinetic energies of 5-40 GeV per nucleon. The
resulting trajectories in the (rho,eps) phase plane are discussed from the
perspective of experimentally exploring the expected first-order hadronization
phase transition with the planned FAIR at GSI or in a low-energy campaign at
RHIC.Comment: 11 pages formatted, 17 eps files for 9 figure
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.